New Preliminary Efficacy Data for Daratumumab Presented at ASH

New Preliminary Efficacy Data for Daratumumab Presented at ASH

[at noodls] – Company Announcement Preliminary safety and efficacy data from final patients in part 1 of study continue to be encouraging Data presented in oral presentation today at the ASH Annual Meeting Part 2 of … more

View todays social media effects on GENC

View the latest stocks trending across Twitter. Click to view dashboard

See who Gencor is hiring next, click here to view

Share this post

Comments (0)